MSD Contact Information Legal Terms MSD Jobs
MESO SCALE DISCOVERY
MESO SCALE DISCOVERY
Catalog
MULTI-ARRAY Detection Technology
Products
Literature & Publications
Applications Literature
Brochures
Customer Presentations
MSD Assay Product Inserts
Technical & Application Notes
MSD Publication References
Our Company
Purchase MSD Assays
Shows & Events We Attend
 



Publications

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?

Collier, P., Watson, C.J., Voon, V., Phelan, D., Jan, A., Mak, G., Martos, R., Baugh, J.A., Ledwidge, M.T., McDonald, K.M.

Journal Eur J Heart Fail. Year 2011
Species Human Volume 13
IL-6, IL-8, MCP-1, TNF-α Page # 1087-1095
Matrix Tested Serum Cytokines & Chemokines

Abstract

AIMS: Hypertension is one of the main drivers of the heart failure (HF) epidemic. The aims of this study were to profile fibro-inflammatory biomarkers across stages of the hypertensive heart disease (HHD) spectrum and to examine whether particular biochemical profiles in asymptomatic patients identify a higher risk of evolution to HF.

METHODS AND RESULTS: This was a cross-sectional observational study involving a population of 275 stable hypertensive patients divided into two different cohorts: Group 1, asymptomatic hypertension (AH) (n= 94); Group 2, HF with preserved ejection fraction (n= 181). Asymptomatic hypertension patients were further subdivided according to left atrial volume index ≥34 mL/m(2) (n= 30) and <34 mL/m(2) (n= 64). Study assays involved inflammatory markers [interleukin 6 (IL6), interleukin 8 (IL8), monocyte chemoattractant protein 1 (MCP1), and tumour necrosis factor α], collagen 1 and 3 metabolic markers [carboxy-terminal propeptide of collagen 1, amino-terminal propeptide of collagen 1, amino-terminal propeptide of collagen 3 (PIIINP), and carboxy-terminal telopeptide of collagen 1 (CITP)], extra-cellular matrix turnover markers [matrix metalloproteinase 2 (MMP2), matrix metalloproteinase 9 (MMP9), and tissue inhibitor of metalloproteinase 1 (TIMP1)], and the brain natriuretic peptide. Data were adjusted for age, sex, systolic blood pressure, and creatinine. Heart failure with preserved ejection fraction was associated with an increased inflammatory signal (IL6, IL8, and MCP1), an increased fibrotic signal (PIIINP and CITP), and an increased matrix turnover signal (MMP2 and MMP9). Alterations in MMP and TIMP enzymes were found to be significant indicators of greater degrees of asymptomatic left ventricular diastolic dysfunction.

CONCLUSION: These data define varying fibro-inflammatory profiles throughout different stages of HHD. In particular, the observations on MMP9 and TIMP1 raise the possibility of earlier detection of those at risk of evolution to HF which may help focus effective preventative strategies.

View Publication


Related Products
Human Chemokine 7-Plex Ultra-Sensitive Kit
Human Chemokine 9-Plex Base Kit
Human Chemokine 9-Plex Tissue Culture Kit
Human Chemokine 9-Plex Ultra-Sensitive Kit
Human Demonstration 10-Plex Base Kit
Human Demonstration 10-Plex Tissue Culture Kit
Human Demonstration 4-Plex Base Kit
Human Demonstration 4-Plex Tissue Culture Kit
Human Demonstration 7-Plex Base Kit
Human Demonstration 7-Plex Tissue Culture Kit

view more

Suggest a Reference


Speak with a Scientist



CAREERS     |     CONTACT US     |     LEGAL     |     PRIVACY
Feedback Form
Feedback Analytics